Antimicrobial use and bacterial resistance

被引:178
作者
Monroe, S [1 ]
Polk, R [1 ]
机构
[1] Virginia Commonwealth Univ Med Coll Virginia, Richmond, VA 23298 USA
关键词
D O I
10.1016/S1369-5274(00)00129-6
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The current epidemic of bacterial resistance is attributed, in part, to the overuse of antibiotics. Recent studies have documented increases in resistance with over-use of particular antibiotics and improvements in susceptibility when antibiotic use is controlled. The most effective means of improving use of antibiotics is unknown. Comprehensive management programs directed by multi-disciplinary teams, computer-assisted decision-making, and antibiotic cycling have been beneficial in controlling antibiotic use, decreasing costs without impacting patient outcomes, and possibly decreasing resistance.
引用
收藏
页码:496 / 501
页数:6
相关论文
共 51 条
  • [21] Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia
    Gleason, PP
    Kapoor, WN
    Stone, RA
    Lave, JR
    Obrosky, DS
    Schulz, R
    Singer, DE
    Coley, CM
    Marrie, TJ
    Fine, MJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (01): : 32 - 39
  • [22] A review of the role of antibiotic policies in the control of antibiotic resistance
    Gould, IM
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (04) : 459 - 465
  • [23] Antibiotic use in humans and bacterial resistance
    Guillemot, D
    [J]. CURRENT OPINION IN MICROBIOLOGY, 1999, 2 (05) : 494 - 498
  • [24] Management of community-acquired pneumonia in the era of pneumococcal resistance -: A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group
    Heffelfinger, JD
    Dowell, SF
    Jorgensen, JH
    Klugman, KP
    Mabry, LR
    Musher, DM
    Plouffe, JF
    Rakowsky, A
    Schuchat, A
    Whitney, CG
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (10) : 1399 - 1408
  • [25] Antibiotic usage and methicillin-resistant Staphylococcus aureus:: an analysis of causality
    Hill, DA
    Herford, T
    Parratt, D
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (05) : 676 - 677
  • [26] USE OF ANTIMICROBIAL DRUGS IN ADULTS BEFORE AND AFTER REMOVAL OF A RESTRICTION POLICY
    HIMMELBERG, CJ
    PLEASANTS, RA
    WEBER, DJ
    KESSLER, JM
    SAMSA, GP
    SPIVEY, JM
    MORRIS, TL
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1991, 48 (06): : 1220 - 1227
  • [27] High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA
    Janoir, C
    Zeller, V
    Kitzis, MD
    Moreau, NJ
    Gutmann, L
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (12) : 2760 - 2764
  • [28] Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital
    John, JF
    Fishman, NO
    [J]. CLINICAL INFECTIOUS DISEASES, 1997, 24 (03) : 471 - 485
  • [29] JOHN JF, INFECT CONTROL HOS S, V21, P22
  • [30] Important and emerging β-lactamase-mediated resistances in hospital-based pathogens:: The amp C enzymes
    Jones, RN
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 31 (03) : 461 - 466